Zurn Elkay Water Solutions reports Tuesday with an unusual split in its positioning signals: options traders have turned sharply more cautious in the past week, even as the lending market remains one of the most relaxed in the building products space.
The clearest shift is in options. The put/call ratio jumped to 0.61 on July 28 — more than two standard deviations above its 20-day average of 0.29. That is the most defensive options read for ZWS in at least a month, and it arrived in a single session, suggesting a deliberate hedge rather than gradual accumulation. The move stands out because it runs counter to the broader price tone: ZWS gained 4.3% on the week and 1.1% on the final session before the print, closing at $49.31.
Short interest adds a separate note of caution, though the lending market itself is uncrowded. Shorts have built steadily — up roughly 33% over the past month to 3.4% of the free float — with most of that increase coming in the past two weeks. Yet borrow conditions are anything but strained. Availability is exceptionally wide at nearly 2,438% of short interest, meaning shares to lend dwarf the current short position by a large multiple. Borrowing costs run at just 0.42% annually. This is a short position that has grown by choice, not by force, and there is plenty of room for it to grow further without triggering squeeze mechanics.
The analyst debate heading into the print is modestly bullish but softening on valuation. Barclays initiated coverage at Overweight with a $59 target in late June. Stifel, which also holds a Buy, trimmed its target from $59 to $56 on July 20 — a signal that the Street has become more selective on price after the stock's strong April run. Bulls point to ZWS's exposure to non-residential infrastructure, a diversified water products portfolio, and a balance sheet that supports M&A. Bears flag slower technology adoption curves, regulatory risk to margins, and a valuation that is not cheap: the stock trades at roughly 26x trailing earnings and 16x EV/EBITDA, with the EV/EBIT factor score ranking in just the 27th percentile versus peers. The consensus is evenly split — five buys against five holds — with mean targets around $56, implying modest upside from current levels.
The print will test whether ZWS's non-residential end markets are holding up well enough to justify the multiple, and whether management's commentary on margin trajectory can reconcile the bullish infrastructure thesis with the caution now visible in options positioning.
See the live data behind this article on ORTEX.
Open ZWS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
